SURVYR

State Street SPDR S&P Biotech ETF (XBI)

As of Jun 30, 2026, filed Aug 28, 2026. Holdings may be out of date: funds report them to the SEC quarterly, with a lag.SEC filing ↗All ETF tools

XBI holds 152 positions; the top 10 are 13.3% of the fund. The largest is Apogee Therapeutics Inc at 1.5%. Biggest sector: Healthcare (34%).

Largest holding
1.5%
Apogee Therapeutics Inc
Top 10 holdings
13.3%
of the fund
Holdings
152
net assets $10.7B
Biggest sector
34%
Healthcare

Cash and derivatives

Grouped, not listed one by one. Futures and swaps count at their gain or loss, not their full exposure.

Cash and money market1 line5.91%
Futures, swaps and options6 lines0.11%

Sectors

Share of the fund in each sector; holdings we can’t match are in “Other / unmapped”.

Healthcare 35.7%Health Care 27.2%Biotech & Healthcare 2.4%Financial Services 0.5%Other / unmapped 34.1%Cash 5.9%Derivatives 0.1% 34%Healthcare
Healthcare35.7%
Health Care27.2%
Biotech & Healthcare2.4%
Financial Services0.5%
Other / unmapped34.1%
Cash5.9%
Derivatives0.1%
How this works & disclosures

Source: State Street SPDR S&P Biotech ETF’s Form NPORT-P for the period ending Jun 30, 2026, filed with the SEC on Aug 28, 2026. Weights are each holding’s value as a share of the fund’s net assets on that date; cash, futures and swaps are grouped. Tickers and sectors are matched by SURVYR. and may be missing for some holdings. Overlap with SURVYR. portfolios is the share of the fund, by weight, in stocks each portfolio holds today.

Data from SEC Form N-PORT, the holdings report funds file with the SEC each quarter; the SEC makes it public about 60 days after the quarter ends. Holdings change; this may be out of date. SURVYR. describes what funds hold and how they have done; it does not manage money or give advice. Not investment advice. Full disclosures

Data from SEC filings. Holdings change; this may be out of date. Not investment advice. Disclosures

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Coteau 0.9 · Oct 21, 2026